Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 MULTIVARIATE MODELLING
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PRODUCT AND BRAND ANALYSIS: MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET
4.2 ROLE OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 RISING DEMAND FOR MOLECULAR DIAGNOSTIC TOOLS TO DIAGNOSE COVID-19
5.1.2 INCREASING PREVALENCE OF INFECTIOUS DISEASES AND CANCER
5.1.3 RISING FUNDING FOR MOLECULAR DIAGNOSIS PRODUCTS
5.1.4 RISING DEMAND FOR POINT-OF-CARE (POC) TESTING
5.1.5 DEVELOPMENT OF COMPANION DIAGNOSTIC ASSAY AND PERSONALIZED MEDICINES
5.2 RESTRAINTS
5.2.1 HIGH COST OF INSTRUMENTATIONS
5.2.2 STRINGENT LEGAL AND REGULATORY STANDARDS ARE EXPECTED TO HAMPER THE MARKET GROWTH
5.2.3 DELAY IN APPROVAL OF EXPERIMENTAL TEST FOR MOLECULAR DIAGNOSIS
5.3 OPPORTUNITIES
5.3.1 RISING GERIATRIC POPULATION
5.3.2 INCREASING ADOPTION OF ANALYSER SOFTWARE FOR MOLECULAR DIAGNOSIS
5.3.3 RISING AWARENESS REGARDING RAPID TECHNOLOGICAL ADVANCEMENTS
5.3.4 RISING HEALTHCARE EXPENDITURE IN DEVELOPING REGION
1.4 CHALLENGES
5.3.5 HIGH COMPETITION AMONG MARKET PLAYERS
5.3.6 DISTURBED SUPPLY CHAIN DUE TO COVID-19
6 IMPACT OF COVID-19 ON THE MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET
6.1 ANALYSIS ON IMPACT OF COVID-19 ON THE MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET
6.2 AFTERMATH OF COVID-19 AND GOVERNMENT INITIATIVES FOR GROWTH OF THE MOLECULAR DIAGNOSTICS MARKET
6.3 IMPACT ON DEMAND
6.4 IMPACT ON SUPPLY CHAIN
6.5 IMPACT ON PRICE
6.6 STRATEGIC INITIATIVES BY MANUFACTURERS
6.7 THE RISING COVID-19 CASES IS LEADING THE MOLECULAR DIAGNOSTICS MARKET
6.8 CONCLUSION
7 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT
7.1 OVERVIEW
7.2 INSTRUMENTS
7.2.1 FULLY AUTOMATED INSTRUMENTS
7.2.2 SEMI-AUTOMATED INSTRUMENTS
7.3 REAGENTS AND KITS
7.4 SERVICES AND SOFTWARES
8 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY
8.1 OVERVIEW
8.2 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS
8.2.1 REAL-TIME PCR
8.2.2 DIGITAL PCR
8.2.3 REVERSE TRANSCRIPTASE PCR
8.2.4 QUANTITATIVE FLUORESCENT PCR
8.2.5 DIRECT LINEAR ANALYSIS
8.2.6 COLD PCR
8.3 NEXT GENERATION SEQUENCING (NGS)
8.4 CYTOGENETICS
8.5 CAPILLARY ELECTROPHORESIS
8.6 IN SITU HYBRIDIZATION (ISH OR FISH)
8.7 MOLECULAR IMAGING
8.7.1 OPTICAL IMAGING
8.7.2 FDG-PET
8.8 MASS SPECTROMETRY (MS)
8.9 CHIPS AND MICROARRAY
8.1 OTHERS
9 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 INFECTIOUS DISEASES
9.2.1 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS
9.2.2 NEXT GENERATION SEQUENCING (NGS)
9.2.3 CYTOGENETICS
9.2.4 CAPILLARY ELECTROPHORESIS
9.2.5 IN SITU HYBRIDIZATION (ISH OR FISH)
9.2.6 MOLECULAR IMAGING
9.2.7 MASS SPECTROMETRY (MS)
9.2.8 CHIPS AND MICROARRAY
9.2.9 OTHERS
9.3 MICROBIOLOGY
9.3.1 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS
9.3.2 NEXT GENERATION SEQUENCING (NGS)
9.3.3 CYTOGENETICS
9.3.4 CAPILLARY ELECTROPHORESIS
9.3.5 IN SITU HYBRIDIZATION (ISH OR FISH)
9.3.6 MOLECULAR IMAGING
9.3.7 MASS SPECTROMETRY (MS)
9.3.8 CHIPS AND MICROARRAY
9.3.9 OTHERS
9.4 BLOOD SCREENING
9.4.1 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS
9.4.2 NEXT GENERATION SEQUENCING (NGS)
9.4.3 CYTOGENETICS
9.4.4 CAPILLARY ELECTROPHORESIS
9.4.5 IN SITU HYBRIDIZATION (ISH OR FISH)
9.4.6 MOLECULAR IMAGING
9.4.7 MASS SPECTROMETRY (MS)
9.4.8 CHIPS AND MICROARRAY
9.4.9 OTHERS
9.5 ONCOLOGY
9.5.1 ONCOLOGY, BY CANCER TYPE
9.5.1.1 BREAST CANCER
9.5.1.2 COLORECTAL CANCER
9.5.1.3 LUNG CANCER
9.5.1.4 PROSTATE CANCER
9.5.1.5 OTHERS
9.5.2 ONCOLOGY, BY TECHNOLOGY
9.5.2.1 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS
9.5.2.2 NEXT GENERATION SEQUENCING (NGS)
9.5.2.3 CYTOGENETICS
9.5.2.4 CAPILLARY ELECTROPHORESIS
9.5.2.5 IN SITU HYBRIDIZATION (ISH OR FISH)
9.5.2.6 MOLECULAR IMAGING
9.5.2.7 MASS SPECTROMETRY (MS)
9.5.2.8 CHIPS AND MICROARRAY
9.5.2.9 OTHERS
9.6 TISSUE TYPING
9.6.1 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS
9.6.2 NEXT GENERATION SEQUENCING (NGS)
9.6.3 CYTOGENETICS
9.6.4 CAPILLARY ELECTROPHORESIS
9.6.5 IN SITU HYBRIDIZATION (ISH OR FISH)
9.6.6 MOLECULAR IMAGING
9.6.7 MASS SPECTROMETRY (MS)
9.6.8 CHIPS AND MICROARRAY
9.6.9 OTHERS
9.7 PHARMACOGENOMICS
9.7.1 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS
9.7.2 NEXT GENERATION SEQUENCING (NGS)
9.7.3 CYTOGENETICS
9.7.4 CAPILLARY ELECTROPHORESIS
9.7.5 IN SITU HYBRIDIZATION (ISH OR FISH)
9.7.6 MOLECULAR IMAGING
9.7.7 MASS SPECTROMETRY (MS)
9.7.8 CHIPS AND MICROARRAY
9.7.9 OTHERS
9.8 PRENATAL TESTS
9.8.1 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS
9.8.2 NEXT GENERATION SEQUENCING (NGS)
9.8.3 CYTOGENETICS
9.8.4 CAPILLARY ELECTROPHORESIS
9.8.5 IN SITU HYBRIDIZATION (ISH OR FISH)
9.8.6 MOLECULAR IMAGING
9.8.7 MASS SPECTROMETRY (MS)
9.8.8 CHIPS AND MICROARRAY
9.8.9 OTHERS
9.9 NEUROLOGICAL DISEASES
9.9.1 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS
9.9.2 NEXT GENERATION SEQUENCING (NGS)
9.9.3 CYTOGENETICS
9.9.4 CAPILLARY ELECTROPHORESIS
9.9.5 IN SITU HYBRIDIZATION (ISH OR FISH)
9.9.6 MOLECULAR IMAGING
9.9.7 MASS SPECTROMETRY (MS)
9.9.8 CHIPS AND MICROARRAY
9.9.9 OTHERS
9.1 CARDIOVASCULAR DISEASES
9.10.1 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS
9.10.2 NEXT GENERATION SEQUENCING (NGS)
9.10.3 CYTOGENETICS
9.10.4 CAPILLARY ELECTROPHORESIS
9.10.5 IN SITU HYBRIDIZATION (ISH OR FISH)
9.10.6 MOLECULAR IMAGING
9.10.7 MASS SPECTROMETRY (MS)
9.10.8 CHIPS AND MICROARRAY
9.10.9 OTHERS
9.11 OTHERS
9.11.1 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS
9.11.2 NEXT GENERATION SEQUENCING (NGS)
9.11.3 CYTOGENETICS
9.11.4 CAPILLARY ELECTROPHORESIS
9.11.5 IN SITU HYBRIDIZATION (ISH OR FISH)
9.11.6 MOLECULAR IMAGING
9.11.7 MASS SPECTROMETRY (MS)
9.11.8 CHIPS AND MICROARRAY
9.11.9 OTHERS
10 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET, BY END USER
10.1 OVERVIEW
10.2 CLINICAL LABORATORIES
10.3 HOSPITAL
10.4 ACADEMICS
11 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET, BY REGION
11.1 MIDDLE EAST AND AFRICA
11.1.1 SOUTH AFRICA
11.1.2 REST OF MIDDLE EAST AND AFRICA
12 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
13 SWOT
14 COMPANY PROFILES
14.1 ABBOTT LABORATORIES
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 F. HOFFMANN-LA ROCHE LTD
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENTS
14.3 ILLUMINA, INC.
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 HOLOGIC, INC.
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENTS
14.5 BIOMÉRIEUX SA
14.5.1 COMPANY SNAPSHOT
14.5.2 COMPANY SHARE ANALYSIS
14.5.3 REVENUE ANALYSIS
14.5.4 PRODUCT PORTFOLIO
14.5.5 RECENT DEVELOPMENT
14.6 AGILENT TECHNOLOGIES, INC.
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 PRODUCT PORTFOLIO
14.6.4 RECENT DEVELOPMENTS
14.7 BD
14.7.1 COMPANY SNAPSHOT
14.7.2 REVENUE ANALYSIS
14.7.3 PRODUCT PORTFOLIO
14.7.4 RECENT DEVELOPMENTS
14.8 BECKMAN COULTER, INC.
14.8.1 COMPANY SNAPSHOT
14.8.2 PRODUCT PORTFOLIO
14.8.3 RECENT DEVELOPMENTS
14.9 BIO-RAD LABORATORIES, INC.
14.9.1 COMPANY SNAPSHOT
14.9.2 REVENUE ANALYSIS
14.9.3 PRODUCT PORTFOLIO
14.9.4 RECENT DEVELOPMENTS
14.1 CEPHEID
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENTS
14.11 GENMARK DIAGNOSTICS, INC.
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENT
14.12 IMMUCOR
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENT
14.13 LIFE TECHNOLOGIES
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENT
14.14 LUMINEX CORPORATION
14.14.1 COMPANY SNAPSHOT
14.14.2 REVENUE ANALYSIS
14.14.3 PRODUCT PORTFOLIO
14.14.4 RECENT DEVELOPMENT
14.15 MERRIDIAN BIOSCIENCE
14.15.1 COMPANY SNAPSHOT
14.15.2 REVENUE ANALYSIS
14.15.3 PRODUCT PORTFOLIO
14.15.4 RECENT DEVELOPMENTS
14.16 MYRIAD GENETICS, INC.
14.16.1 COMPANY SNAPSHOT
14.16.2 REVENUE ANALYSIS
14.16.3 PRODUCT PORTFOLIO
14.16.4 RECENT DEVELOPMENTS
14.17 QIAGEN
14.17.1 COMPANY SNAPSHOT
14.17.2 REVENUE ANALYSIS
14.17.3 PRODUCT PORTFOLIO
14.17.4 RECENT DEVELOPMENTS
14.18 QUIDEL CORPORATION
14.18.1 COMPANY SNAPSHOT
14.18.2 REVENUE ANALYSIS
14.18.3 PRODUCT PORTFOLIO
14.18.4 RECENT DEVELOPMENT
14.19 SIEMENS HEALTHCARE GMBH
14.19.1 COMPANY SNAPSHOT
14.19.2 REVENUE ANALYSIS
14.19.3 PRODUCT PORTFOLIO
14.19.4 RECENT DEVELOPMENTS
14.2 THERMO FISHER SCIENTIFIC INC.
14.20.1 COMPANY SNAPSHOT
14.20.2 REVENUE ANALYSIS
14.20.3 PRODUCT PORTFOLIO
14.20.4 RECENT DEVELOPMENTS
15 QUESTIONNAIRE
16 RELATED REPORTS
List of Table
LIST OF TABLES
TABLE 1 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 2 MIDDLE EAST AND AFRICA INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 3 MIDDLE EAST AND AFRICA INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 4 MIDDLE EAST AND AFRICA REAGENTS AND KITS IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 MIDDLE EAST AND AFRICA SERVICES AND SOFTWARES IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 6 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 7 MIDDLE EAST AND AFRICA POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 MIDDLE EAST AND AFRICA POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 9 MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 MIDDLE EAST AND AFRICA CYTOGENETICS IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 MIDDLE EAST AND AFRICA CAPILLARY ELECTROPHORESIS IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 MIDDLE EAST AND AFRICA INS SITU HYBRIDIZATION (ISH OR FISH) IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 MIDDLE EAST AND AFRICA MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 MIDDLE EAST AND AFRICA MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 15 MIDDLE EAST AND AFRICA MASS SPECTROMETRY (MS) IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 MIDDLE EAST AND AFRICA CHIPS AND MICROARRAY IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 MIDDLE EAST AND AFRICA OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 19 MIDDLE EAST AND AFRICA INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 MIDDLE EAST AND AFRICA INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 21 MIDDLE EAST AND AFRICA MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 MIDDLE EAST AND AFRICA MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 23 MIDDLE EAST AND AFRICA BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019-2028 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 28 MIDDLE EAST AND AFRICA TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 MIDDLE EAST AND AFRICA TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 30 MIDDLE EAST AND AFRICA PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 MIDDLE EAST AND AFRICA PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 32 MIDDLE EAST AND AFRICA PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 MIDDLE EAST AND AFRICA PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 34 MIDDLE EAST AND AFRICA NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 MIDDLE EAST AND AFRICA NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 36 MIDDLE EAST AND AFRICA CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 37 MIDDLE EAST AND AFRICA CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 38 MIDDLE EAST AND AFRICA OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 39 MIDDLE EAST AND AFRICA OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 40 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 41 MIDDLE EAST AND AFRICA CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 42 MIDDLE EAST AND AFRICA HOSPITAL IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 43 MIDDLE EAST AND AFRICA ACADEMICS IN MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 44 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 45 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 46 MIDDLE EAST AND AFRICA INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 47 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 48 MIDDLE EAST AND AFRICA POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 49 MIDDLE EAST AND AFRICA MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 50 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 51 MIDDLE EAST AND AFRICA ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019-2028 (USD MILLION)
TABLE 52 MIDDLE EAST AND AFRICA ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 53 MIDDLE EAST AND AFRICA PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 54 MIDDLE EAST AND AFRICA MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 55 MIDDLE EAST AND AFRICA PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 56 MIDDLE EAST AND AFRICA TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 57 MIDDLE EAST AND AFRICA BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 58 MIDDLE EAST AND AFRICA CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 59 MIDDLE EAST AND AFRICA NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 60 MIDDLE EAST AND AFRICA INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 61 MIDDLE EAST AND AFRICA OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 62 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 63 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 64 SOUTH AFRICA INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 65 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 66 SOUTH AFRICA POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 67 SOUTH AFRICA MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 68 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 69 SOUTH AFRICA ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019-2028 (USD MILLION)
TABLE 70 SOUTH AFRICA ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 71 SOUTH AFRICA PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 72 SOUTH AFRICA MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 73 SOUTH AFRICA PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 74 SOUTH AFRICA TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 75 SOUTH AFRICA BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 76 SOUTH AFRICA CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 77 SOUTH AFRICA NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 78 SOUTH AFRICA INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 79 SOUTH AFRICA OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 80 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 81 REST OF MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
List of Figure
LIST OF FIGURES
FIGURE 1 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET: DBMR VENDOR SHARE ANALYSIS
FIGURE 9 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 10 NORTH AMERICA IS EXPECTED TO DOMINATE THE MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET AND GROWING WITH THE HIGHEST SHARE IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 11 THE INCREASING PREVALENCE OF INFECTIOUS DISEASES AND CANCER IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 INSTRUMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET
FIGURE 14 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020
FIGURE 15 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020
FIGURE 16 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2020
FIGURE 17 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2020
FIGURE 18 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET: SNAPSHOT (2020)
FIGURE 19 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET: BY COUNTRY (2020)
FIGURE 20 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)
FIGURE 21 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)
FIGURE 22 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET: BY PRODUCT (2021 & 2028)
FIGURE 23 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET: COMPANY SHARE 2020 (%)
